Capecitabine linked to rare eruptive keratoacanthoma in colorectal cancer patient
Full story
A 75-year-old woman receiving capecitabine for metastatic colorectal cancer developed eruptive keratoacanthoma. This rare skin condition is known to mimic squamous cell carcinoma.
A 75‑year‑old woman on capecitabine for metastatic colorectal cancer developed eruptive keratoacanthoma, a rare skin condition that can mimic squamous cell carcinoma.